InnoPharmax Inc. (4172.TWO)

TWD 17.1

(-0.87%)

Total Liabilities Summary of InnoPharmax Inc.

  • InnoPharmax Inc.'s latest annual total liabilities in 2023 was 48.64 Million TWD , down -16.56% from previous year.
  • InnoPharmax Inc.'s latest quarterly total liabilities in 2024 Q2 was 44.36 Million TWD , down 0.0% from previous quarter.
  • InnoPharmax Inc. reported annual total liabilities of 58.3 Million TWD in 2022, up 136.9% from previous year.
  • InnoPharmax Inc. reported annual total liabilities of 24.61 Million TWD in 2021, down -88.2% from previous year.
  • InnoPharmax Inc. reported quarterly total liabilities of 44.36 Million TWD for 2024 Q2, down 0.0% from previous quarter.
  • InnoPharmax Inc. reported quarterly total liabilities of 48.64 Million TWD for 2023 FY, down -16.56% from previous quarter.

Annual Total Liabilities Chart of InnoPharmax Inc. (2023 - 2019)

Historical Annual Total Liabilities of InnoPharmax Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 48.64 Million TWD -16.56%
2022 58.3 Million TWD 136.9%
2021 24.61 Million TWD -88.2%
2020 208.6 Million TWD 156.13%
2019 81.44 Million TWD 0.0%

Peer Total Liabilities Comparison of InnoPharmax Inc.

Name Total Liabilities Total Liabilities Difference
Allied Biotech Corporation 910.11 Million TWD 94.655%
GeneFerm Biotechnology Co., Ltd. 282.53 Million TWD 82.781%
Easywell Biomedicals, Inc. 589.98 Million TWD 91.754%
TTY Biopharm Company Limited 3.36 Billion TWD 98.556%
Synmosa Biopharma Corporation 3.62 Billion TWD 98.659%
Orient EuroPharma Co., Ltd. 6.64 Billion TWD 99.268%
Center Laboratories, Inc. 6.78 Billion TWD 99.283%
Tien Liang BioTech Co., Ltd. 161.05 Million TWD 69.793%
Orient Pharma Co., Ltd. 892.18 Million TWD 94.547%
Johnson Chemical Pharmaceutical Works Co., Ltd. 320.99 Million TWD 84.844%
Excelsior Biopharma Inc. 472.87 Million TWD 89.712%
DV Biomed Co., Ltd. 765.87 Million TWD 93.648%
Foresee Pharmaceuticals Co., Ltd. 616.93 Million TWD 92.114%
Handa Pharmaceuticals, Inc. 280.88 Million TWD 82.68%
UniPharma Co., Ltd. 37.4 Million TWD -30.074%
Anxo Pharmaceutical Co., Ltd. 1.01 Billion TWD 95.209%
Alar Pharmaceuticals Inc. 76.08 Million TWD 36.063%
Winston Medical Supply Co., Ltd. 373.87 Million TWD 86.988%
Mercury Biopharmaceutical Corporation 49.72 Million TWD 2.156%
Bioray Biotech Co., Ltd 108.75 Million TWD 55.266%
TSH Biopharm Corporation Limited 133.62 Million TWD 63.593%